TREM2 and early-onset autosomal dominant Alzheimer disease: Triggering Receptor Expressed on Myeloid Cells 2 (TREM2), a lipid-binding receptor expressed on the cell surface, has previously been shown to maintain the metabolic fitness of microglia in Alzheimer’s disease (AD) (29–33).